Cargando…
Indirect Neonatal Hyperbilirubinemia and the Role of Fenofibrate as an Adjuvant to Phototherapy
Background: One of the most prevalent illnesses in neonates that needs care and treatment is neonatal jaundice. Several drugs are used as pharmacological modalities for treating hyperbilirubinemia, like intravenous immunoglobulin, D-penicillamine, metalloporphyrin, phenobarbital, zinc sulfate and cl...
Autores principales: | Shabo, Salam K., Gargary, Khalaf H., Erdeve, Omer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378335/ https://www.ncbi.nlm.nih.gov/pubmed/37508689 http://dx.doi.org/10.3390/children10071192 |
Ejemplares similares
-
Challenges of phototherapy for neonatal hyperbilirubinemia (Review)
por: Wang, Juan, et al.
Publicado: (2021) -
Parental experiences of home phototherapy for neonatal hyperbilirubinemia
por: Pettersson, Miriam, et al.
Publicado: (2022) -
Effects of Phototherapy on the Serum Magnesium Level in Neonates with Indirect Hyperbilirubinemia: A Prospective Cohort Study
por: Eghbalian, Fatemeh, et al.
Publicado: (2022) -
Blood Eosinophil Levels in Newborns with Severe Indirect Hyperbilirubinemia Treated with Phototherapy
por: Aydın, Banu, et al.
Publicado: (2014) -
Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis
por: Kuitunen, Ilari, et al.
Publicado: (2022)